Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Soomro, H.
Right arrow Articles by Davies, N.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Quantifying changes in retinal anatomy after interventions for diabetic maculopathy

Hibba Soomro

Department of Ophthalmology, Chelsea & Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK, hibba{at}doctors.org.uk

Lesley Burnett

Nigel Davies

Introduction

Diabetic maculopathy remains the major cause of loss of vision in diabetes. There is evidence to show that control of lipid levels reduces the amount of exudate in diabetic maculopathy, but to date there is no information on the effect of lipid reduction on diabetic macular oedema.

Purpose

The purpose of this case series was to compare retinal thickness using optical coherence tomography (OCT) of patients with exudative diabetic maculopathy whose only change in management was starting statins or increasing the current dose.

MethodsV"

Four patients with exudative diabetic maculopathy had serial OCT measurements to assess retinal thickness M before and after commencing or increasing their statin dose. Results

Analysis showed a reduction of macula thickness in all cases. Visual acuity also improved during the time course of the measurements.

Conclusion

Statins may aid management of diabetic maculopathy by reducing macular oedema. This case series gives the first quantified evidence of the effect of statins on reduction of diabetic macular oedema.

Key Words: Exudative diabetic maculopathy • optical coherence tomography • statins.

The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 4, 181-185 (2007)
DOI: 10.1177/14746514070070040701
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?